Response to letter 'Lymphocyte counts and the risk of COVID-19 in people with MS'

Mult Scler. 2021 Sep;27(10):1626-1627. doi: 10.1177/1352458520965468. Epub 2020 Oct 16.

Authors

Floor C Loonstra, Zoé LE van Kempen, Eva M Strijbis, Joep Killestein¹, Elske Hoitsma², Jop P Mostert³

Affiliations

¹ Department of Neurology, Amsterdam Neuroscience, MS Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
² Department of Neurology, Alrijne Hospital, Leiden, The Netherlands.
³ Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands.

PMID: 33064043
DOI: 10.1177/1352458520965468

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Humans
Lymphocyte Count
SARS-CoV-2